baber/WOPTO huggingface dataset:
Patent MX-2021003536-A (MX)
Title: Rate matching for wideband carrier operation in nr-u.
Inventor: KOORAPATY HAVISH
IPC: H04W74/08
Filed: 2019-09-30
Abstract: An example method is performed by a wireless device in a wireless communication network. The method comprises receiving, from a base station, a control message allocating resources in a bandwidth part for a downlink transmission, the bandwidth part including unlicensed spectrum and being divided into a plurality of bandwidth pieces corresponding to bandwidth units over which listen-before-talk (LBT) is performed. The radio resources used for the downlink transmissions exclude (e.g., by puncturing or rate-matching around) one or more guard bands of a bandwidth piece that is sensed as free for transmission.
Patent MX-2021004079-A (MX)
Title: Female disposable absorbent product with enhanced capacity for containment and distribution of body fluids.
Inventor: AMIAMA DI MARZIO TOMÁS LUIS
IPC: A61F13/15
Filed: 2021-04-08
Abstract: Female disposable absorbent article (1) with improved ability to concentrate and distribute body fluids, which includes a front region (F), a back region (B) and an intermediate region (M), a contacting side with the wearer's body and an opposite side of contact with the wearer's underwear. The absorbent article (1) is composed of a fluid-permeable upper sheet (2) on the side in contact with the wearer's body, a fluid-impermeable back sheet (3) on the side in contact with the wearer's underwear, a core absorbent (6) arranged between the upper (2) and posterior (3) sheet, where on the side in contact with the user's body, there is a set of recordings that cover the upper sheet (2) and the absorbent core (6), said assembly comprising: (i) at least one containment channel (20) running along the inner contour of the absorbent core (6), forming an inner region (21) and an outer region (22); and (ii) a central section with a pattern of circular engravings (30) arranged in the inner region (21), where the pattern of circular engravings (30) is established so that it has a central column (31) located on the longitudinal axis (L) and formed by engraved circles, and on each side of the central column (31), there is at least one side column (32) formed by engraved circles.
Patent MX-2021006824-A (MX)
Title: Method for preparing ammonium metatungstate.
Inventor: WEILAND ANJA
IPC: C01G41/00
Filed: 2019-12-18
Abstract: The present invention relates to a method for preparing ammonium metatungstate using a reverse osmosis cell and to a device for carrying out the claimed method.
Patent MX-2021006977-A (MX)
Title: Anellosomes and methods of use.
Inventor: KAHVEJIAN AVAK
IPC: C12N15/86
Filed: 2019-12-12
Abstract: This invention relates generally to anellosomes and compositions and uses thereof.
Patent MX-2021007804-A (MX)
Title: Continuous feed of antistatic agent for gas phase polymerization process.
Inventor: POZZER DIHOGENES ADRIANO
IPC: C07F5/06
Filed: 2019-12-28
Abstract: Methods may include reacting an antistatic agent with at least one alkylaluminum to form an antistatic complex, and may further include feeding the antistatic complex into a polymerization process. Methods of using an antistatic agent in a polymerization process may include feeding the antistatic agent into the polymerization process and, subsequently, reacting the antistatic agent with at least one alkylaluminum.
Patent MX-2021009421-A (MX)
Title: All natural, non-toxic sublingual drug delivery systems.
Inventor: EDALAT PAUL
IPC: A61K47/30
Filed: 2015-05-13
Abstract: All natural non-toxic sublingual delivery systems improve absorption and onset profiles for numerous actives, along with bioavailability and pharmacokinetics results that are better than expected for families of moieties compounds and legacy-patented formulations. All natural non-toxic sublingual delivery systems improve absorption and onset profiles for numerous actives, along with bioavailability and pharmacokinetics results that are better than expected for families of moieties compounds and legacy-patented formulations. Ball valves and ball valve components usable to control the flow of fluids and methods for manufacturing said ball valve components. Ball valves include a ball member comprising two curved segments of like shape and size, which are integrally joined and disposed symmetrically to one another relative to the axis of rotation of the ball member. A bore extends through the joined first and the second curved segments, wherein the first end of the bore is located on the first curved segment and the second end of the bore is located on the second curved segment. Each curved segment is disposed symmetrically to one another, relative to the axis of rotation. The area of separation, between the curved segments, defines shoulders of like configuration, wherein each shoulder is located symmetrically with respect to the other relative to the ball member's axis of rotation.
Patent MX-2021010047-A (MX)
Title: A process of making a short-circuited diode that prevents electrocution.
Inventor: PACHECO PENA JOHN JAIRO
IPC: H01L21/66
Filed: 2020-02-18
Abstract: A process of making a short-circuited diode that changes the properties of an electric current that passes through the short-circuited diode so that the current does not harm a human that contacts the current after it passes through the diode.
Patent MX-2021010991-A (MX)
Title: Portable terminal accessory device for holographic projection and user interface.
Inventor: GRIFFITH TAYLOR SCOTT
IPC: G03H1/22
Filed: 2020-03-11
Abstract: A holographic display system for a portable electronic device. The display system includes a case configured to receive the portable electronic device and a projector coupled to the case by a first hinge element. The projector includes a projector screen for generating images. A reflective element is coupled to the projector by a second hinge element. The reflective element is oriented to reflect light from the images in order to create holographic images perceptible to a user of the portable electronic device. The case may include a connector for receiving, from the portable electronic device, a video signal defining the images. The holographic display system may further include a substantially transparent touch screen attached to the first hinge element.
Patent MX-2022001107-A (MX)
Title: Universal hitch intermodal well car system.
Inventor: BROWN ANDREW
IPC: B62D33/00
Filed: 2022-01-26
Abstract: A system for a well car includes a frame, a hitch coupled to the frame near the first end of the frame, and a first deck coupled to the frame. The frame includes a first pair of sockets located near a first end of the frame and a second pair of sockets located near a second end of the frame. Each socket of the first pair of sockets is configured to engage a support casting of a first pair of support castings located at a first position along a length of a well car. Each socket of the second pair of sockets is configured to engage a support casting of a second pair of support castings located at a second position along the length of the well car. The first deck is configured to hold wheels of a trailer when the trailer is coupled to the hitch.
Patent MX-2022002417-A (MX)
Title: Genetically engineered oncolytic vaccinia viruses and methods of uses thereof.
Inventor: ARAI YUKINORI
IPC: A61K35/768
Filed: 2020-08-27
Abstract: The present invention provides pharmaceutical compositions comprising an oncolytic vaccinia virus and methods of using such pharmaceutical compositions for treating a subject having a cancer.
Patent MX-2022006875-A (MX)
Title: System for the processing and resupply of pulp as well as a method for the construction thereof.
Inventor: STOCKINGER CHRISTIAN
IPC: D21H17/33
Filed: 2022-06-06
Abstract: The present disclosure relates to a system for pulp processing and resupply of production-quality pulp to at least one fiber molding system, where the system is constructed in scalable modular form. For this, the system includes at least one supply module (110) and one or more process modules (120). The supply module (110) and the process modules (120) are equipped with a plurality of interfaces (150), matched to one another in each case, in order to connect supply and process modules (110, 120) to one another. This may guarantee the infrastructure supply of the process modules (120). The pulp or the constituents and starting materials may be received via at least one inlet (130) and transported between the process modules (120) to provide the production-quality pulp (160) via an outlet (140) for use by at least one fiber molding system.
Patent MX-2022008892-A (MX)
Title: Reception device, transmission device, reception method, and transmission method.
Inventor: NISHIO AKIHIKO
IPC: H04W56/00
Filed: 2020-12-10
Abstract: An appropriate MAC Control Element (CE) operation start timing control process is realized in an NTN system. A terminal 100 comprises: a wireless reception unit 106 that receives a MAC CE and an offset value (K<sub>MAC_ACTION</sub>, etc.); and a control unit 110 that, on the basis of the offset value, sets a slot for starting an operation based on a MAC CE control command.
Patent MX-2022009823-A (MX)
Title: Matrix assisted two component roof coating system and method.
Inventor: CHICH ADEM
IPC: B29C70/20
Filed: 2021-02-17
Abstract: A two component roof coating system and method includes a sufficiently porous fabric attachable to a roof deck. A first component of the two component roof coating may be applied to the fabric after it is attached to the roof. Alternatively, fabric may be pre- soaked with the first component prior to attachment. A second component of the two component roof coating may then be applied to the fabric. The first and second components react with each other to form a waterproof roof coating. The fabric can hold the components in place and prevent sagging.
Patent MX-2022013237-A (MX)
Title: Cross-linked maltodextrins for the oral delivery of biological actives.
Inventor: TROTTA FRANCESCO
IPC: A61K9/51
Filed: 2020-01-10
Abstract: The invention relates to oral administration of biological actives, in particular of insulin, comprising the use of a cross-linked starchy material as a delivery system.
Patent MX-2022013398-A (MX)
Title: Tetrahydroisoquinoline compounds as nrf2 activators.
Inventor: RAY NICHOLAS CHARLES
IPC: A61P35/00
Filed: 2021-04-22
Abstract: The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
Patent MX-2022013713-A (MX)
Title: Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane.
Inventor: MANEVAL DANIEL C
IPC: A61K31/337
Filed: 2014-10-03
Abstract: Provided herein is combination therapy containing an anti-hyaluronan agent, such as a polymer-conjugated hyaluronan-degrading enzyme, and a tumor-targeted taxane, and optionally a further chemotherapeutic agent such as a nucleoside analog. The combination therapy can be used in methods of treating cancers, and in particular solid tumor cancers.
Patent MX-2022014111-A (MX)
Title: Methods for isolating gamma delta t cells.
Inventor: NUSSBAUMER OLIVER
IPC: A01N1/02
Filed: 2021-05-12
Abstract: The invention relates to methods for the isolation of non-haematopoietic tissue-resident lymphocytes, particularly Î³Î´ T cells. Such Î³Î´ T cells include non-VÎ´2 cells, e.g. VÎ´1, VÎ´3 and VÎ´5 cells and such non-haematopoietic tissues include skin and gut. It will be appreciated that such isolated non-haematopoietic tissue-resident lymphocytes find great utility in adoptive T cell therapies, chimeric receptor therapies and the like. Also provided are methods for expanding isolated tissue-resident lymphocytes, particularly methods for isolating and expanding Î³Î´ T cells. The present invention also relates to both individual cells and populations of cells produced by the methods described herein.
Patent MX-2022015547-A (MX)
Title: Method and device for twisting single cables.
Inventor: STAUBLI DOMINIK
IPC: H01B13/02
Filed: 2020-06-26
Abstract: The invention relates to a method and a device (400) for twisting single cables (11, 12) about a twisting axis (V). The single cables (11, 12) each run along a cable axis (v1, v2) and have wires (11a, 12a), which are twisted in a strand twisting direction (S, Z) to form a strand, and also each have a first cable end (15, 16) and a second cable end (17, 18). The first cable ends (15, 16) are held separately by a single rotating unit (41, 42) in each case. The second cable ends (17, 18) are held by a twisting unit (30). The second cable ends (17, 18) are rotated jointly about the twisting axis (V) counter to the strand twisting direction (S, Z) to produce a twisted cable bundle (10). During the joint rotation, the first cable ends (15, 16) are rotated separately about a cable axis (v1, v2) of the respective single cable (11, 12), in the same rotation direction as the joint rotation. The single cables are each relieved of torsion thereby.
Patent MX-2022015997-A (MX)
Title: Hot melt pressure sensitive adhesive compositions and articles including the same.
Inventor: MANSOUR AMEARA S
IPC: A61F13/56
Filed: 2021-07-16
Abstract: The invention features a disposable absorbent article including a hot melt pressure sensitive adhesive composition including from 10% by weight, to 35% by weight of a styrene block copolymer having an average styrene content of from 10% by weight to 25% by weight and an average di-block content of from 1:2% by weight to 65% by weight, from 30% by weight to 65% by weight of a hydrogenated hydrocarbon tackifying agent having a weight average molecular weight (Mw) of at least 1000 grams/mole and from 10% by weight to 40% by weight of a plasticizer.
Patent MX-PA00008011-A (MX)
Title: PROCESS AND FURNACE FOR THE PRODUCTION OF TiO2.
Inventor: LAILACH GUENTER
IPC: C01G23/053
Filed: 1999-02-16
Abstract: A process for the production of titanium dioxide by dissolving titanium raw materials with sulfuric acid, producing a metal sulfate-containing titanyl sulfate solution, hydrolyzing the titanyl sulfate, separating the titanium dioxide hydrate from the metal sulfate-containing sulfuric acid by filtration, optionally bleaching the titanium dioxide hydrate by reducing treatment in acidic solution and calcining the titanium dioxide hydrate optionally mixed with doping chemicals and rutile nuclei to titanium dioxide, characterized in that the sulfate-containing titanium dioxide hydrate is dried in a dryer at temperatures from 90 to 400 °C, preferably 90 to 200 °C, especially 90 to 150 °C, and the titanium dioxide hydrate dust from the dryer exhaust is separated by filtration, the dried titanium dioxide hydrate is calcined in a rotary kiln directly heated with flue gasses at temperatures in the range from 800 to 1100 °C (solids temperature) and the exhaust is de-dusted and de-sulfurized as well as a calcining furnace for the production of titanium dioxide from dried sulphate-containing titanium dioxide hydrate in the form of a rotary kiln with a length-diameter ratio in the range of 5 to 10.
Patent MX-PA00011416-A (MX)
Title: Nucleotide sequences coding for the pfk gene.
Inventor: BETTINA MOCKEL
IPC: C12N9/12
Filed: 2000-11-21
Abstract: Isolated polynucleotide (I), from coryneform bacteria, is at least 70% identical with a sequence that encodes a polypeptide (IIa) containing a fully defined sequence (330 amino acids (aa)) (S2), encodes a polypeptide (IIb) containing a sequence at least 70% identical with (S2), is complementary (IIc) to (IIa) or (IIb) or contains at least 15 consecutive nucleotides (nt) of (IIa-c). An Independent claim is also included for production of L-aa, especially lysine, by fermenting a coryneform bacterium in which the pfk gene, or related nucleic acid, is amplified, especially over expressed.
Patent MX-PA00012924-A (MX)
Title: Method for organising a chip card so that it can be used as server in an internet-type network.
Inventor: MACAIRE ALAIN
IPC: G06F12/00
Filed: 1999-06-24
Abstract: The invention concerns chip cards for use as server in association with a digital data transmission network terminal. The invention is characterised in that the chip card comprises a microprocessor and memories which contain programmes and data for interpreting the URL's coming from the network terminal, translating them into elementary commands of the chip card and formatting the response to the terminal. Some of these functions can be performed by the terminal with which the chip card is associated. The invention is applicable to networks transmitting digital data and programmes of the Internet or mobile telephone system type.
Patent MX-PA01008496-A (MX)
Title: Compositions comprising nickel and their use as catalyst in oxidative dehydrogenation of alkanes.
Inventor: LIU YUMIN
IPC: C07C45/34
Filed: 2000-02-22
Abstract: Catalysts and methods for alkane oxydehydrogenation are disclosed. The catalysts of the invention generally comprise (i) nickel or a nickel-containing compound and (ii) at least one or more of titanium (Ti), tantalum (Ta), niobium (Nb), cobalt (Co), hafnium (Hf), tungsten (W), yttrium (Y), zinc (Zn), zirconium (Zr), or aluminum (Al), or a compound containing one or more of such element(s). In preferred embodiments, the catalyst is a supported catalyst, the alkane is selected from the group consisting of ethane, propane, isopropane, isobutane, n-butane and ethyl chloride, molecular oxygen is co-fed with the alkane to a reaction zone maintained at a temperature ranging from about 250 °C to about 350 °C, and the ethane is oxidatively dehydrogenated to form the corresponding the alkene with an alkane conversion of at least about 10 % and an alkene selectivity of at least about 70 %.
Patent MX-PA02001669-A (MX)
Title: Bioavailable dosage form of isotretinoin.
Inventor: INDERDEEP BHATIA
IPC: A61K9/14
Filed: 2001-04-09
Abstract: The present invention relates to a bioavailable pharmaceutical composition of 13-cis vitamin A acid (also known as 13-cis retinoic acid and isotretinoin) and a process for preparing the same. 13-cis vitamin A acid is a relatively water insoluble compound that degrades when exposed to light and atmospheric oxygen. Due to its instability and relative insolubility, the bio-availability of the drug after oral administration is difficult to achieve and has always been a challenge to a development pharmacist. It would therefore be desirable to provide a dosage form in which the drug is stable and predictably bioavailable.
Patent MX-PA02004581-A (MX)
Title: Two step park release valve.
Inventor: ANDREW MARSH
IPC: B60T17/22
Filed: 2002-05-08
Abstract: A braking system control requires that a first or service braking system be actuated before a second or parking braking system can be released to prevent unexpected movements. A sensor senses that the service brakes are engaged and controls a device to release the parking brakes. A latch ensures that the parking brakes remain released. For example, a piston and check valve form the sensor and latch. Service brake pressure works against the piston. Above a threshold level, service brake pressure drives the piston to open a valve that provides pressurized air to a parking brake release system. Once released, the check valve directs parking brake release pressure to the piston to keep the valve open.
Patent MX-PA02006081-A (MX)
Title: Method for production of nphosphonomethylglycine.
Inventor: WULFF CHRISTIAN
IPC: C07F9/38
Filed: 2000-12-22
Abstract: The invention relates to a method for production of Nphosphonomethylglycine, by reaction of a hexahydrotriazine derivative with a triacylphosphite. The method produces Nphosphonomethylglycine in a simple and costeffective manner and in high yield.
Patent MX-PA02006257-A (MX)
Title: Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease.
Inventor: NASHOLD FAYE E
IPC: A61K9/70
Filed: 2000-12-21
Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
Patent MX-PA02006362-A (MX)
Title: Methods of detection of amyloidogenic proteins.
Inventor: KRISHNAMURTHY GIRIJA
IPC: A61P25/28
Filed: 2000-12-01
Abstract: A methodassay for detecting various aggregated forms of amyloid peptide using amyloidspecific spectroscopic probes, such as Congo red and related analogs, is described. Such an assay could be used to assess the aggregation state of the peptide in the presence of other potential inhibitors of fibrillogenesis, providing a useful model by which to test inhibitors of aggregation in in vitro models. Results of such an assay can be useful in determining the stage at which the process of aggregation can be intervened to reduce the toxicity of amyloid peptide to neuronal cells. In specific examples, circular dichroism, UV absorption, and fluorescence spectroscopy are each used to evaluate the aggregation form of bgr;amyloid peptide.
Patent MX-PA02006684-A (MX)
Title: Rheology modified compositions and modification agents.
Inventor: EDGAR FRANKLIN HOY
IPC: B01J13/00
Filed: 2001-01-05
Abstract: A method of making a rheology modified aqueous composition, particularly useful for drilling, milling and mining applications, is disclosed. The method includes admixing, with a clay and water, a material or materials whose constituents substantially conform to the proportions of the empirical formula MmMn(OH)(2mplus;3nplus;qaplus;br)(Aq)a(Br)b.xH2O, where M represents at least one divalent metal cation and m is an amount of from greater than zero to about 8; where M represents at least one trivalent metal cation and n is an amount of from greater than zero to about 6; where A is an anion or negativevalence radical that is monovalent or polyvalent, and a is an amount of A ions of valence q, provided that if A is monovalent, a is from greater than zero to about 8, and if A is polyvalent, a is from greater than zero to about 4; where B is a second anion or negativevalence radical that is monovalent or polyvalent, and where b is an amount of B ions of valence r and b is from zero to about 4; provided (mplus;n) is greater than or equal to 1; further provided that qaplus;br cannot be greater than 2mplus;3n and provided that qa cannot equal 2mplus;3n; and still further provided that (2mplus;3nplus;qaplus;br) is less than 3; and where xH2O represents excess waters of hydration, with x being zero or more. Calcined hydrotalcite and hydrotalcitelike materials are particularly preferred as starting materials. Optionally, an aluminum oxide, a nitrogencontaining compound, or both may be added. The resulting composition is preferably an elastic solid exhibiting stressdependent fluidity, desirable temperature resistance, inhibition of reactivity, relatively low cost, and pressure resistance. A dry composition and method of making are also disclosed.
Patent MX-PA02008697-A (MX)
Title: Use of interleukin 6 antagonists for the treatment of diseases characterised by high levels of aromatase.
Inventor: REED MICHAEL JOHN
IPC: A61K38/17
Filed: 2000-03-06
Abstract: The invention described herein relates to the use of human interleukin 6 antagonists, totally incapable of binding to gp 130, as specific inhibitors of the enzyme aromatase, useful for the treatment of hormone dependent tumours, and particularly tumours of the breast.